Billiontoone (NASDAQ:BLLN) Upgraded to “Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Billiontoone (NASDAQ:BLLN) from a hold rating to a buy rating in a research note published on Saturday morning.

Other equities analysts have also recently issued reports about the company. Zacks Research raised Billiontoone to a “hold” rating in a report on Tuesday, December 2nd. JPMorgan Chase & Co. decreased their price target on Billiontoone from $150.00 to $145.00 and set an “overweight” rating on the stock in a research note on Wednesday, December 10th. Stifel Nicolaus started coverage on Billiontoone in a research note on Monday, December 1st. They set a “buy” rating and a $145.00 price objective for the company. BTIG Research cut their price objective on Billiontoone from $160.00 to $140.00 and set a “buy” rating for the company in a report on Thursday. Finally, Piper Sandler restated an “overweight” rating on shares of Billiontoone in a research note on Wednesday, December 10th. Six research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $129.57.

Billiontoone Stock Performance

NASDAQ BLLN opened at $73.51 on Friday. Billiontoone has a twelve month low of $66.00 and a twelve month high of $138.70. The company has a market capitalization of $3.36 billion and a PE ratio of 735.10. The company has a 50-day simple moving average of $85.55.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings results on Wednesday, March 4th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.07. The business had revenue of $96.05 million for the quarter, compared to the consensus estimate of $85.85 million. The business’s revenue for the quarter was up 113.0% compared to the same quarter last year.

Institutional Investors Weigh In On Billiontoone

A number of hedge funds and other institutional investors have recently bought and sold shares of BLLN. Rossby Financial LCC bought a new position in Billiontoone in the 4th quarter valued at $25,000. Wells Fargo & Company MN acquired a new stake in shares of Billiontoone in the fourth quarter valued at $76,000. Smartleaf Asset Management LLC bought a new position in shares of Billiontoone in the fourth quarter valued at about $80,000. Nano Cap New Millennium Growth Fund L P bought a new position in shares of Billiontoone in the fourth quarter valued at about $82,000. Finally, Renaissance Capital LLC acquired a new position in Billiontoone during the 4th quarter worth about $201,000.

Trending Headlines about Billiontoone

Here are the key news stories impacting Billiontoone this week:

• Positive Sentiment: Q4 earnings beat and rapid revenue growth — BillionToOne reported $0.11 EPS vs. $0.04 consensus and revenue of $96.05M (vs. $85.85M est.), with revenue up ~113% year-over-year; results and commentary point to accelerating demand. View Press Release
• Positive Sentiment: Raised FY‑2026 revenue guidance — company lifted 2026 revenue guidance to $430M–$445M vs. consensus near $356M, implying materially stronger top‑line growth than analysts expected. Press Release
• Positive Sentiment: Earnings call & investor materials highlight strategy and growth drivers — management commentary and the slide deck underscored durable revenue expansion and product/market traction that support the raised guidance. Earnings Highlights
• Positive Sentiment: Analyst support: Guggenheim reaffirmed a “buy” with a $120 PT — another buy-side vote that can buoy sentiment despite mixed firm-level price target moves. Benzinga
• Positive Sentiment: Positive coverage piece framing BLLN as an attractive investment — broader bullish narratives and coverage can amplify buying interest following the beat and guidance lift. Article
• Neutral Sentiment: Analyst deep‑dive and metric comparisons — outlets (e.g., Zacks) are parsing metrics vs. estimates and prior periods; useful for modeling but not new catalyst. Zacks
• Neutral Sentiment: Q4 snapshot pieces summarize results for retail/institutional readers — helpful context but unlikely to move price independently. LMOnline
• Neutral Sentiment: Short‑interest data appears anomalous/unchanged (reports show zeros/NaN); no clear short squeeze signal from these feeds. (Data quality issue; monitor official FINRA reports.)
• Negative Sentiment: Wells Fargo cut its price target to $90 and set an “equal weight” rating — a downgrade in conviction from that shop could cap near‑term upside and weigh on sentiment for more conservative investors. Benzinga
• Negative Sentiment: BTIG trimmed its target from $160 to $140 (still a “buy”) — target cuts reduce the extent of analyst-driven upside, even if the rating remains positive. Street Insider

Billiontoone Company Profile

BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.

BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.